GENFIT

H.08
No items found.
No items found.

GENFIT is a biopharmaceutical company dedicated to the discovery and development of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases where there are considerable unmet medical needs. Its most advanced drug candidate, elafibranor, is being evaluated in a pivotal Phase 3 clinical trial as a potential treatment for NASH. GENFIT is also developing a new, non-invasive and easy-to-access blood-based in vitro diagnostic test to identify patients with NASH.